Gilliland Jeter Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.11M Sell
12,245
-301
-2% -$70.2K 0.81% 32
2026
Q1
$3.07M Sell
12,546
-25
-0.2% -$5.82K 0.91% 30
2025
Q4
$2.6M Sell
12,571
-152
-1% -$30.1K 0.79% 33
2025
Q3
$2.36M Buy
12,723
+27
+0.2% +$4.63K 0.73% 34
2025
Q2
$1.94M Sell
12,696
-235
-2% -$36.1K 0.63% 39
2025
Q1
$2.14M Buy
12,931
+160
+1% +$25K 0.76% 35
2024
Q4
$1.85M Sell
12,771
-270
-2% -$41.8K 0.62% 39
2024
Q3
$2.11M Sell
13,041
-170
-1% -$27.1K 0.68% 37
2024
Q2
$1.93M Sell
13,211
-43
-0.3% -$6.39K 0.65% 41
2024
Q1
$2.1M Sell
13,254
-2,488
-16% -$396K 0.73% 36
2023
Q4
$2.47M Buy
+15,742
New +$2.41M 1.02% 27

Other funds holding JNJ

Gilliland Jeter Wealth Management's JNJ Position: Q2 2026 in Review

Gilliland Jeter Wealth Management reduced its Johnson & Johnson (JNJ) stake by 2.4% in Q2 2026, selling an estimated $70.2K and leaving 12,245 shares worth $3.11M. The position accounts for 0.81% of the portfolio, ranked #32.

Gilliland Jeter Wealth Management first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 3,157 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Gilliland Jeter Wealth Management held 12,245 shares of Johnson & Johnson worth $3.11M as of Q2 2026.
  • Gilliland Jeter Wealth Management sold 301 Johnson & Johnson shares in Q2 2026, an estimated $70.2K.
  • Johnson & Johnson made up 0.81% of Gilliland Jeter Wealth Management's portfolio in Q2 2026, its #32 holding.
  • Gilliland Jeter Wealth Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 3,157 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Gilliland Jeter Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.